ZYME Q1 2022 Earnings — Zymeworks Inc. Revenue & Financial Results | Market Cap Arena

ZYMEZymeworks Inc.

$2B

Q1 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M+197.5% YoY

Gross Profit

-$61M-3162.5% margin

Operating Income

-$73M-3793.6% margin

Net Income

-$73M-3790.4% margin

EPS (Diluted)

$-1.18

QoQ Revenue Growth

-90.4%

Cash Flow

Operating Cash Flow

-$55M

Free Cash Flow

-$60M

Stock-Based Comp.

-$8M

Balance Sheet

Total Assets

$430M

Total Liabilities

$148M

Stockholders' Equity

$282M

Cash & Equivalents

$276M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$644,000	+197.5%
Gross Profit	-$61M	-$44M	-38.9%
Operating Income	-$73M	-$45M	-61.8%
Net Income	-$73M	-$45M	-62.9%

Revenue Segments

Other Product

$2M100%